Aim: To evaluate whether serum platelets Mean Platelet Volum (MPV), and Red Cell Distribution width (RDW) are useful as predictors of preterm labour (PL) in patients with preterm labour (PL), and to compare the clinical efficacy of various serum inflammatory markers to predict the risk of preterm delivery (PD). Materials, and methods: The main group consisted of pregnant women who were earlier than the 37th gestational week. The control group has consisted of pregnant bigger than 37th weeks of gestation. The patients with PL who participated in the study group were divided into early preterm labour (EPL), and late preterm labour (LPL) groups. The two groups were investigated in terms of clinical aspects of RDW, and MPV and serum markers studied at admission. ROC curve analysis was used to determine the optimal MPV, RDW cut-off levels predicting PL. Results: Neutrophil (NEU), MPW, RDW, and neutrophil to lymphocyte ratio (NLR) were significantly higher in LPL than in women who gave birth at term (p=0.006, OR=1.411; p14,5, and MPV>9,6 have the highest sensitivity and specificity. RDW may be more significant than measuring any of the individual markers in the simultaneous use of preterm delivery. The simultaneous use of RDW and MPV with existing markers to increase our identifying abilities of preterm labour may be stronger than that of any of the individual markers.
Purpose The aim of the study was to determine the accuracy of fetal sex definition by measuring the yolk sac size and the yolk sac–fetal pole distance in the first trimester via ultrasound (US) screening. Methods We enrolled 92 gestational women in this prospective study. In the first trimester of US examination, the gestational sac, the gestational sac–fetal pole distance, and the yolk sac size were measured. When the fetal pole was in the longitudinal position, the distance between the fetal pole and the yolk sac was measured in millimeters (mm). The crown–rump length (CRL) was measured in the same position. US examination at 22 weeks was performed to determine whether the fetal gender was male or female. The genders of the fetuses were recorded. The sexes were also confirmed and recorded after birth. Results Fifty-five (59.8%) of the newborns were found to be male, while 37 (40.2%) of them were found to be female. We compared the yolk sac size and the yolk sac–fetal pole distance in both the female and male groups. We found that the genders showed a significant difference in terms of yolk sac–fetal pole distance, whereas the yolk sac size showed no significant difference between the genders. The optimal cutoff value of the yolk sac–fetal pole distance was 1.80 mm, with 70% sensitivity and 67% specificity for female gender prediction. The distance also showed an independent association with gender prediction in the first trimester. Conclusion Yolk sac–fetal pole distance may have the potential to predict gender in the first trimester of pregnancy.
8 December 2020 in Gynecology Obstetrics & Reproductive Medicine
Objective: The aim of this study is to evaluate sialic acid levels in cord blood samples of infants of natal diabetic and non-diabetic pregnancies and to assess the correlation of sialic acid levels with the poor neonatal outcomes.Study Design: The study was conducted between January 2016 and February 2018 with 48 diabetic patients and 39 non-diabetic patients. The inclusion criteria were participants should have an oral glucose tolerance test, patients should not have rheumatic or metabolic diseases, and the follow-up visits during whole pregnancy should be in our hospital. Sialic acid levels of the participants were assessed from the newborn cord blood within the first 6-24 hours postnatally. Also mean platelet volume, mean corpuscular hemoglobin concentration, mean corpuscular hemoglobin, platelet, bilirubin values were recorded as well as the age, gravida, parity, gestational week of the participant mothers and type of delivery, gender, weight, height and the APGAR score of the newborn, and whether insulin was used or not. SPSS statistical program was used to interpret the obtained data.Results: A total of 87 patients were included in the study, 48 from the diabetic patient group and 39 from the control group. There was no difference in sialic acid levels between the two groups (p=0.155). When the diabetic group was divided into subgroups, the group with the highest sialic acid level was type I diabetes (46.25±3.6). The others, in decreasing order, were participants with Type II diabetes (33.00±4.1) and gestational diabetes (20.87±3.7) and the difference was statistically significant (p=0.001). Those who were diabetic and on insulin treatment had significantly higher sialic acid values than those who were on diabetic diet only (p=0.007). When the sialic acid is compared in participants with higher blood glucose levels with those with a lower blood glucose level sialic acid concentration was lower in those with higher blood glucose. (p=0.006). Between these two groups, no difference was found regarding the poor neonatal outcomes and laboratory parameters (p >0.05).Conclusion: Infants of diabetic and non-diabetic patients in pregnancy had no difference in sialic acid blood levels and neonatal outcomes in cord blood. However, among diabetic groups, sialic acid levels were higher in type I diabetic group than in other diabetic groups